Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.3K
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
2.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Regioselective synthesis of aza-saccharins <i>via</i> anionic [1,4] Fries-type rearrangement of aryl sulfonimidoyl fluorides.

Chemical science·2026
Same author

Regioselective synthesis of aza-saccharins <i>via</i> anionic [1,4] Fries-type rearrangement of aryl sulfonimidoyl fluorides.

Chemical science·2026
Same author

Transient Extensive Portal Venous Gas in a Dialysis Patient.

Cureus·2025
Same author

Correction: Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer.

Breast cancer research : BCR·2025
Same author

RAR-related orphan receptor alpha and the staggerer mice: a fine molecular story.

Frontiers in endocrinology·2024
Same author

RNA-Binding Proteins and Their Emerging Roles in Cancer: Beyond the Tip of the Iceberg.

International journal of molecular sciences·2023

Related Experiment Video

Updated: Mar 28, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.9K

STAT5 in Cancer and Immunity.

Aradhana Rani1, John J Murphy1

  • 1Department of Biomedical Sciences, University of Westminster , London, United Kingdom .

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|December 31, 2015
PubMed
Summary

Signal transducers and activators of transcription 5 (STAT5) are crucial for cell growth and survival. Aberrant STAT5 activation in cancer promotes tumor progression, making it a promising therapeutic target.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Signal transducers and activators of transcription 5 (STAT5a and STAT5b) are key proteins in cellular signaling pathways.
  • STAT5 proteins are activated by Janus-activated kinases (JAK) downstream of cytokine receptors, regulating proliferation, differentiation, and survival.
  • Aberrant constitutive activation of STAT5 is observed in many human tumors, contributing to tumor cell survival and disease progression.

Purpose of the Study:

  • To elucidate the critical role of STAT5 in immune function and cancer.
  • To highlight STAT5's involvement in regulating T regulatory cells (Tregs) and antitumor immunity.
  • To emphasize the therapeutic potential of targeting STAT5 in cancer treatment.

Main Methods:

  • The study reviews the JAK-STAT signaling pathway and the role of STAT5 in cytokine signaling.

More Related Videos

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

20.4K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K

Related Experiment Videos

Last Updated: Mar 28, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.9K
Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

20.4K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K
  • It examines the involvement of STAT5 in the development and function of Tregs.
  • The research analyzes the association between STAT5 activation and tumor cell proliferation, invasion, and survival.

    • Main Results:

    • STAT5 proteins are essential regulators of vital cellular functions, including proliferation, differentiation, and survival.
    • STAT5 plays a critical role in immune homeostasis and the function of Tregs.
    • Consistently activated STAT5 is linked to suppressed antitumor immunity and enhanced tumor cell proliferation, invasion, and survival.

    Conclusions:

    • STAT5 is a critical mediator of biological actions for the gamma-chain (γ(c)) family of cytokines in the immune system.
    • STAT5 activation is significantly associated with tumor cell survival and malignant progression.
    • Targeting STAT5 therapeutically holds significant promise for cancer treatment.